Academy of Finland
Funding decision
Applicant / Contact person Kopra, Kari
Organisation University of Turku
Project title LanthaGlo homogeneous assay techniques for inhibitor and antibiotic screening
Decision No. 323433
Decision date 07.05.2019
Funding period 01.09.2019 - 31.08.2024
Funding 438 874
WebFOCUS Report
Project description
Lack of simple and sensitive assay methodologies have slow down both biological and drug screening studies with different proteins and enzymes. During the recent years, multiple potential target proteins have been identified. However, without the methods to study function of these proteins and ability to target them with modulator molecules, final validation of these target proteins cannot be performed. Recently, many particle-based assay systems have been developed to answer these questions. The project aims not only to develop a novel Eu(III)-particle based homogeneous assay platform to monitor actions of potential drug targets e.g. K-Ras and eIF4A, but also select aptamers to be used as a binder and modulator for these targets. The project will follow a highly translational approach where selected aptamer and developed Eu(III)-particles are used not only to study biological functions but also screening and characterization of allosteric modulators in collaboration with our partners.